Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)

NCT06453876 is registered in ClinicalTrials.gov with Jesper Kjaergaard as lead sponsor.

NCT NCT06453876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06453876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)
Lead sponsor
Jesper Kjaergaard
Phase
Phase 3
Overall status
Recruiting
Start date
June 17, 2026
Completion date
October 31, 2029
Enrollment
210 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary embolism